DIY swab could revolutionize anal cancer screening for HIV patients

NCT ID NCT07438080

Recruiting now Prevention Sponsor: Centre Hospitalier Universitaire de la Réunion Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether people living with HIV can accurately collect their own swab samples to screen for HPV, a virus that can lead to anal cancer. Researchers will compare self-swabs to those taken by a doctor and ask participants which method they prefer. If self-screening works well, it could make regular cancer screening easier and more private for this high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV self-test (vaginal self-swab)
What this could lead to: If self-screening proves accurate and acceptable, it could make anal cancer screening easier and more accessible for people with HIV, potentially catching pre-cancers earlier.
What could go wrong: This is a small, early-stage study focused on accuracy and acceptability, not on preventing cancer itself. Self-swabbing may be less accurate than a clinician's swab, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV

Contacts and locations

Locations

CegiDD Saint Pierre
RECRUITING

Saint-Pierre, France
Cegidd Saint Paul
RECRUITING

Saint-Paul, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.